Prevalence of kras p.(g12c) in stage iv nsclc patients in the netherlands; a nation-wide retrospective cohort study

HIGHLIGHTS

• who: Betzabel N. Cajiao Garcia from the University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands have published the paper: Prevalence of KRAS p.(G12C) in stage IV NSCLC patients in the Netherlands; a nation-wide retrospective cohort study, in the Journal: (JOURNAL)
• what: The aim of this study was to establish the prevalence of KRAS p.(G12C) mutations in the Netherlands for stage-IV non-squamous NSCLC patients to determine the impact of the pending EMA approval of sotorasib and other KRAS p.(G12C) inhibitors.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.